WebHome - X4 Pharmaceuticals Chronic Neutropenic Disorders Leveraging our unparalleled expertise in diseases of the immune system and CXCR4 biology, we aim to bring innovative treatments to people with chronic neutropenic disorders. Learn More Pipeline
See Also: Home Phone Preview / Show details
WebX4 Pharmaceuticals does not review or control the content on the website to which this hyperlink connects and this hyperlink does not constitute an endorsement by X4 …
See Also: Contact Support Preview / Show details
Web51-200 employees Headquarters Boston, Massachusetts Type Public Company Founded 2014 Specialties Rare disease and primary immunodeficiencies Locations Primary 61 N Beacon St Boston, …
See Also: Phone Number Preview / Show details
WebX4 Pharmaceuticals is a Biotechnology Research, Drug Manufacturing & Research, and Biotechnology company located in Cambridge, Massachusetts with $9.00 Million in …
See Also: Contact Support Preview / Show details
WebBOSTON, June 30, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a leader in the discovery and development of novel small-molecule therapeutics to benefit …
See Also: Finance Preview / Show details
Web(857) 529-8300 Website www.x4pharma.com Revenue $28M Stock Symbol XFOR Industry Pharmaceuticals Healthcare X4 Pharmaceuticals's Social Media Is this data correct? …
See Also: Health Preview / Show details
Web51-100 Post-IPO Equity Public www.x4pharma.com 6,333 Highlights Stock Symbol NASDAQ:XFOR Acquisitions 1 Total Funding Amount $277.1M Contacts 57 Employee …
See Also: Contact Support Preview / Show details
WebThe transfer agent and registrar for the common stock of X4 Pharmaceuticals, Inc. stock is: Computershare Trust Company, N.A. 250 Royall Street Canton, Massachusetts 02021
See Also: Computer Preview / Show details
WebMay 4, 2023 · X4 Pharmaceuticals Announces Positive Phase 3 Results Showing Mavorixafor Reduced the Rate, Severity, and Duration of Infections vs. Placebo in …
See Also: Phone Number Preview / Show details
WebDec 16, 2022 · Last updated: December 16, 2022 X4 Pharmaceuticals, Inc. and its subsidiaries recognize the importance of protecting your privacy. By using our Website, …
See Also: Phone Number Preview / Show details
WebJun 30, 2022 · BOSTON, June 30, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted …
See Also: Phone Number Preview / Show details
WebX4 Pharmaceuticals is a clinical-stage oncology company, which develops oral small molecule CXCR4 antagonists for the treatment of refractory solid tumors. It focuses on …
See Also: Atm Preview / Show details
WebX4 Pharmaceuticals 4,895 followers on LinkedIn. A clinical-stage biopharma company focused on the development of novel therapeutics for the treatment of rare diseases. X4 …
See Also: Atm Preview / Show details